Iranian Journal of Public Health (Oct 2015)

Pharmacotherapy in Endocrinology: Diabetes, Obesity, and Hyper¬lipidemia- Review Article

  • Mania RADFAR,
  • Mohammad ABDOLLAHI

Journal volume & issue
Vol. 43, no. Supple 1

Abstract

Read online

The field of endocrine pharmacology is very wide but most of studies in the recent years from the world and Iran have focused on diabetes, osteoporosis, and lipid disorders. In the present review, we tried to evaluate the improvements and publications in that field briefly. Interestingly, many of studies have focused on agents that have traditional and natural origin. Although few basic studies have gone on the direct line to complete preclinical and some clinical trial studies, there are many non-clinical studies that have proved efficacy of many compounds in endocrine diseases but these studies were not continued at clinical stages to reach a drug. However, it is appreciable that, some researchers have given novel ideas that deserve investment by grant bodies to reach out valuable works. We believe that science of endocrine pharmacology is still young and more quality studies are still needed to introduce effective medications for diseases like diabetes and osteoporosis or even obesity and lipid disorders. Keywords: Pharmacotherapy, Diabetes, Osteoporosis, Lipid disorders, Emerging therapies